Supplementary Figure S1 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy

Key Points

• Improved disease free survival outcomes observed in muscle-invasive bladder cancer cases after therapy.
• Significant findings highlighted the association between transcriptomic profiles and prognosis in 84 TURBT cases.
• Subtyping analysis using various models revealed distinct outcomes related to prognosis and treatment efficacy.
• Identifying favorable prognostic markers may impact future therapeutic strategies and patient outcomes.